Next Article in Journal
Physical Fitness and Body Composition in Women with Systemic Lupus Erythematosus
Previous Article in Journal
Use of Magnetic Resonance Imaging in Evaluating Fetal Brain and Abdomen Malformations during Pregnancy

Medicina 2019, 55(2), 56; https://doi.org/10.3390/medicina55020056

Review
Recently Discovered Interstitial Cell Population of Telocytes: Distinguishing Facts from Fiction Regarding Their Role in the Pathogenesis of Diverse Diseases Called “Telocytopathies”
1
Institute of Histology and Embryology, Faculty of Medicine, Comenius University in Bratislava, 813 72 Bratislava, Slovakia
2
Fifth Department of Internal Medicine, Faculty of Medicine, Comenius University in Bratislava, 813 72 Bratislava, Slovakia
3
Institute of Anatomy, Second Faculty of Medicine, Charles University, 128 00 Prague, Czech Republic
4
Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University in Bratislava, 813 72 Bratislava, Slovakia
*
Author to whom correspondence should be addressed.
Received: 4 December 2018 / Accepted: 11 February 2019 / Published: 18 February 2019

Abstract

:
In recent years, the interstitial cells telocytes, formerly known as interstitial Cajal-like cells, have been described in almost all organs of the human body. Although telocytes were previously thought to be localized predominantly in the organs of the digestive system, as of 2018 they have also been described in the lymphoid tissue, skin, respiratory system, urinary system, meninges and the organs of the male and female genital tracts. Since the time of eminent German pathologist Rudolf Virchow, we have known that many pathological processes originate directly from cellular changes. Even though telocytes are not widely accepted by all scientists as an individual and morphologically and functionally distinct cell population, several articles regarding telocytes have already been published in such prestigious journals as Nature and Annals of the New York Academy of Sciences. The telocyte diversity extends beyond their morphology and functions, as they have a potential role in the etiopathogenesis of different diseases. The most commonly described telocyte-associated diseases (which may be best termed “telocytopathies” in the future) are summarized in this critical review. It is difficult to imagine that a single cell population could be involved in the pathogenesis of such a wide spectrum of pathological conditions as extragastrointestinal stromal tumors (“telocytomas”), liver fibrosis, preeclampsia during pregnancy, tubal infertility, heart failure and psoriasis. In any case, future functional studies of telocytes in vivo will help to understand the mechanism by which telocytes contribute to tissue homeostasis in health and disease.
Keywords:
telocytes; interstitial Cajal-like cells; telocytopathies; tissue regeneration; telocytoma

1. Introduction

The human body consists of more than 200 morphologically and functionally different cells, although the exact number is still unclear. Additionally, most of these cells are found in different stages of their development [1]. Since the time of eminent German pathologist Rudolf Virchow (1821–1902), we have known that many pathological processes originate directly from cells. Not only did he consolidate the idea of cellular changes as the basis of disease, Virchow also advocated the promotion of histopathology to relevant and important scientific disciplines, and he riveted the attention of physicians and scientists to cells [2,3]. Perhaps Virchow’s legacy is one of the main reasons why the discovery of new cell populations within the human body is usually rooted in attempts to elucidate a disease whose etiopathogenesis is unknown. The preliminary results of such endeavors have a tendency to spark the interest of many other fellow scientists, a phenomenon known as the “snowball effect”—one study builds upon the previous one and the number of papers pointing to the importance of these cells in the pathogenesis of diseases often grows exponentially, resulting in the substantial attractiveness of the topic and quickly yielding high numbers of citations.
We hold the opinion that a similar principle also applies to a recently discovered cell population—telocytes, which have been continuously described in the pathogenesis of many different diseases over the last 10 years. Considering the extent of this publication activity, we are somewhat surprised that until now there has not been a proposal to introduce a new term referring to the group of diseases caused by the reduced number or impaired function of telocytes, for example, “telocytopathies”.
In the first place, it is necessary to point out that telocytes were discovered in 2005, only 13 years ago, in the loose connective tissue of the pancreas [4]. Because of their resemblance to enteric interstitial/pacemaker cells (cellulae entericae interstitiales stimulantes), eponymously termed interstitial cells of Cajal (in recognition of the scientific contribution of the Spanish neurohistologist and Nobel Prize laureate Santiago Ramón y Cajal), the new term “interstitial Cajal-like cells” was proposed for this newly discovered population of pancreatic cells. This discovery is attributed to the team of cell biologists and pathologists from Romania led by Professor Laurentiu M. Popescu (1944–2015). Professor Popescu was considered one of the greatest Romanian cell biologists and is also renowned internationally. He was awarded multiple prestigious prizes for his scientific achievements and was selected as a president or a member of many international scientific organizations [5]. In 2000, Professor Popescu also founded the Journal of Cellular and Molecular Medicine (2017 Impact Factor 4.302). Over the following years, interstitial Cajal-like cells were described in many organs of the human body; however, it was not until 2010 when Professor Popescu, in cooperation with Professor Maria-Simonetta Faussone-Pellegrini, realized that the name “interstitial Cajal-like cells” is quite long and impractical; besides, in some organs their function was different from the original interstitial cells that Cajal found within the gut wall. The same year, Professors Popescu and Faussone-Pellegrini authored a revolutionary publication “TELOCYTES—A case of serendipity: The winding way from interstitial cells of Cajal (ICC), via interstitial Cajal-like cells (ICLC) to telocytes” [6], where they proposed the new term “telocytes” (a reference to Aristotle, according to whom “telos” was an individual’s greatest potential). As of 2018, this term has been cited, depending on the source database, more than 300 times. The discovery of telocytes was truly a lucky event since today telocytes and interstitial Cajal cells are regarded as completely different cell populations, although they can occur simultaneously in the interstitium of various organs [7]. Oddly, this revolutionary discovery of 2005 and the intense research during the following years were not enough for telocytes to be included in the official, widely accepted histological nomenclature Terminologia Histologica [8] containing all terms associated with cells, tissues and organs at the microscopic level [9]. Furthermore, telocytes are not yet mentioned in any internationally accepted textbook of histology or histopathology. This might be explained by the fact that telocytes are not widely accepted by researchers as an individual cell population. Some of them consider telocytes as only a type of “CD34-positive stromal cell”, which serve as progenitor/stem cells during the processes of regeneration and reparation [10,11,12], some think telocytes can be derived from endothelial cells [13], while others offer an alternative explanation, that telocytes could be mistaken for lymphatic endothelial cells caught in the longitudinal section [14,15]. On the other hand, several articles regarding telocytes were published in such prestigious journals as Nature [16] and Annals of the New York Academy of Sciences [17]. This could be understood as proof of at least partial acceptance of telocytes as a newly discovered and distinct cell population within the scientific community.
The current state of knowledge indicates that telocytes form three-dimensional networks in various organs. Telocytes are typically described as cells with small bodies and one to five very long cytoplasmic processes, whose width is under the resolution power of light microscopes [18], contrasted with their length, which is considered by some authors to be the second greatest in the human body, after that of neuronal axons, reaching up to hundreds of micrometers [19]. Telocytes reportedly cover a wide spectrum of functions ranging from a role in bioelectrical activity, pacemaking and motility/contractility regulation (as within the myometrium or heart [20,21,22,23,24,25]), through the mediation of intercellular signaling between immune cells, stem cells, blood vessels or epithelial cells [26], to the orchestration of tissue regeneration and the promotion of angiogenesis, because telocytes are an important source of niche signals to stem cells [16,27,28]. Our critical review of the literature brings a concise overview of telocyte occurrence in different organs of the human body, discusses their supposed functions and last but not least ponders over the likelihood that one cell population is substantially responsible for the development of such a wide spectrum of different diseases. Thus, our principal goal is to bring a valuable contribution to the dispute of whether or not telocytes should be granted the status of an individual and unique cell population, finally puzzling out the dissonance between the myth vs. the reality attitude on the hypothesis of “telocytopathies”.

2. Telocytes as Principal Cells of Diverse Organs of the Human Body

In recent years, telocytes have been described in almost all organs of the human body. Although telocytes were previously thought to be localized predominantly in the organs of the digestive system, as of 2018 they have also been described in the lymphoid tissue, skin, respiratory system, urinary system, meninges and the organs of the male and female genital tracts (details in Table 1). For instance, telocytes have been detected in the stroma of the major accessory glands of the digestive system, namely in the interstitium of the pancreas [29]. They contribute to intercellular communication among pancreatic cells using gap junctions. Telocytes have also been implicated in the tumorigenesis of rare extragastrointestinal stromal tumors [30]. In the liver, telocytes have been detected in the space around the blood sinusoids [31]. Liver telocytes should be responsible for both the regeneration and fibrosis of this organ [32]. However, we could not find the essential explanation of the relationship between telocytes and stellate cells of Ito, whose role in liver regeneration and fibrosis development has been described and confirmed multiple times [33,34]. Pasternak et al. [35] used immunohistochemical methods to confirm the presence of telocytes in the muscle layer of the gallbladder. We consider this occurrence as logical, considering that the gallbladder sprouts and grows from the wall of the primitive gut, which implies that the muscle tissue of the gallbladder and the gut (the location of the interstitial cells of Cajal) has the same embryonic origin. They also revealed that the number of telocytes was lower in patients with gallstones than in healthy controls. These findings can be linked to another study in which the authors concluded that a reduction in the telocyte population could be an important etiopathogenetic factor in the development of cholelithiasis [36]. Nicolescu et al. [37] studied the salivary glands, namely the parotid gland. They demonstrated the presence of telocytes using both electron microscopy and immunohistochemistry. These techniques revealed that telocytes are located mainly in the connective tissue septa of the parotid gland, while their cytoplasmic projections connect glandular cells, blood capillaries and nerve fibers. Researchers have also been able to detect telocytes in other exocrine glands that have no developmental or other connection with the digestive system, such as the prostate [38] and mammary gland [39]. Their role in age-related degenerative changes in the prostate, characterized by alterations in the smooth muscle tone of the fibromuscular stroma, remains questionable.
Telocytes have also been repeatedly described in the muscle tissue [40], with the bulk of attention focused on the myocardium. Interestingly, their function in the heart was shown to be considerably different from that of telocytes in other organs [41,42,43]. Recent research indicated that the subepicardial layer of the heart contains cardiogenic stem cell niches. In these specialized spots, telocytes establish a three-dimensional support network for cardiac progenitor cells. Animal-model research has shown that telocytes are present at these sites from the early stages of the heart embryogenesis, where they create a specific microenvironment, which cardiogenic cells require to properly settle and proliferate [44]. Zhou et al. [45] went even further and used the term “nurse cells”, which reflects the potential role of telocytes in the regeneration and reparation of the damaged myocardium. The role of telocytes in myocardial regeneration in humans (in contrast to animal models) remains questionable. Although telocyte numbers were shown to be reduced in end-stage failing hearts [46], in our previous study we found no link between telocyte numbers and the dynamics of the reparative mechanisms in the human heart after myocardial infarction [47].

3. Telocytes as Morphologically Unique and Functionally Diverse Cells

The morphological characteristics of telocytes have been thoroughly covered in a large number of original [83,84,85,86] as well as review papers [87,88,89,90]. The archetypal morphological signs of telocytes are small inconspicuous cell bodies [91], whose morphology is in sharp contrast with the cytoplasmic projections—telopodes [92]. These processes are some of the longest cellular processes in the human body, reaching up to several hundred micrometers in length, and their appearance is absolutely unique [93]. Telopodes are characterized as having moniliform design, with alternating thin and thick segments referred to as podomers and podoms, respectively [94]. Details regarding telocyte morphology can be found elsewhere, e.g., [95]. Typical for telocytes is also the formation of homo- and heterocellular junctions with a diverse array of cells and other tissue components, including stem cells and cells of the immune system [96,97]. Even though telocyte morphology is routinely studied with a transmission electron microscope, immunophenotyping using immunohistochemistry is also frequently employed. However, the specific immunohistochemical marker expressed only in telocytes is yet to be found. The most commonly used antibodies are those against CD34 [98], c-kit (CD117) [99] and platelet-derived growth factor receptor alpha and beta (PDGFRα and -β) [100,101] antigens. Moreover, there are also organ-specific subtypes of telocytes, which display an additional positivity, e.g., telocytes in the female reproductive system are positive for estrogen [102] and progesterone receptors [103]. Telocytes, along with fibroblasts, are currently considered constituent fixed cells of the connective tissue. Fibroblasts and their products (collagen and elastic fibers) play a role in mechano-transduction, but also importantly contribute to tissue remodeling and inflammatory processes. On the other hand, telocytes are responsible for mechano-sensitivity and contribute to reparative and regenerative mechanisms by functionally connecting different types of cells via their long cytoplasmic projections [104]. For these reasons, telocytes are frequently referred to as “connecting cells”. Telocytes are posited to have diverse roles in different organs. The most apt summary of these probable functions was provided by Creţoiu et al. [105]:
  • Telocytes are cells of the connective tissue, which are functionally distinct from both stem cells and fibroblasts. Their principal functions are cellular signaling, the maintenance of tissue homeostasis and remodeling and assistance during the formation of new blood vessels (angiogenesis).
  • The processes of telocytes engage in intercellular communication not only with other telocytes, but also with adjacent structures and cell populations such as blood vessels, nerve endings, smooth muscle cells and cells of glandular epithelia. This communication is enabled by homo- or heterocellular cell-to-cell junctions or by extracellular vesicles.
  • Telocyte-produced extracellular vesicles play roles in the regulation of stem cell function, tissue regeneration, immunological surveillance and the maintenance of homeostatic processes.
Some researchers, like American neuroscientist Lawrence Edelstein, go even further to highlight the putative functions of this newly described cell population. Professor Edelstein compared the network comprising the processes of telocytes to a primitive cellular communication network, similar to the nervous system at the cellular level [106,107].

4. Diseases Associated with Telocytes, “Telocytopathies”

Telocytes were firstly linked to the interstitial/pacemaker cells of Cajal, whose detailed description served as the basis for the discovery of telocytes. The pacemaking, which controls the contractile activity of the gastrointestinal muscles, is the essence of their significant physiological role—the orchestration of the normal peristaltic activity of the digestive system [108]. The enteric interstitial cells of Cajal are also known to be the cellular origin of gastrointestinal stromal tumors (GISTs), whose characteristic histological feature is positivity for the c-kit (CD117) antigen [109,110]. GISTs are the most common mesenchymal tumors affecting the gastrointestinal tract. Interestingly, in the case of specific PDGFRα-mutant GISTs, preliminary results indicate that even telocytes can be a source cell population of this tumor [111]. Since telocytes, formerly known as interstitial Cajal-like cells, are routinely described within the glands associated with the digestive tube (the pancreas and liver with the gallbladder and hepatobiliary tree), they are implicated as the possible source of extragastrointestinal stromal tumors (eGISTs) localized in these organs [112]. Interestingly, eGISTs are rarely localized in organs outside of the digestive system, such as the prostate [113], the vagina [114], the uterus [115] or the inferior vena cava [116]. The common feature of all these tumors is the immunohistochemical positivity for the c-kit (CD117) antigen. C-kit is one of the immunohistochemical markers of telocytes in some organs, albeit an interesting observation is that specific telocytes of the gut tube are c-kit-negative [63]. Building upon the occurrence of telocytes in all of the aforementioned extragastrointestinal organs, future research will possibly reveal that eGISTs are actually “telocytomas”, tumors of telocyte origin. This term was introduced by Ricci et al. [111] in 2018. The term “telocytoma” is also applicable to other neoplasms such as inflammatory fibroid polyps usually localized in the submucosa of the gastrointestinal tract. Most inflammatory fibroid polyps bear PDGFRα-mutations (PDGFRα is one of the typical antigens of telocytes of the gastrointestinal tract), so in this case the designation “telocytoma” properly represents not only the genuine neoplastic nature of this tumor, but also its plausible histotypic lineage [111].
The diversity of telocytes extends beyond their morphology and functions, as they have a potential role in the etiopathogenesis of different diseases. The most commonly described telocyte-associated diseases (which may be best termed “telocytopathies” in the future) are summarized in Table 2. It is difficult to imagine that a single cell population could be involved in the pathogenesis of such a wide spectrum of pathological conditions. For this reason, the table should be taken with a pinch of salt, as much research remains to be done to elucidate the real importance of telocytes in these conditions. We structured the table rather unconventionally by incorporating the impact factors of the journals in which the studies were published. Our goal was to highlight the fact that even seemingly unlikely associations between these newly described cells and various acute and chronic diseases were published in prestigious scientific journals. On the other hand, a sizeable proportion of these discoveries was published in the Journal of Cellular and Molecular Medicine, the academic journal established by the discoverer of telocytes, Professor Laurentiu Popescu. Taking this finding into consideration may diminish the credibility of the published results regarding the supposedly groundbreaking roles of telocytes in the etiopathogenesis of various diseases. We emphasize that we are in no way casting doubt on the importance of the results published in this journal.
In the recent literature, few human studies have investigated changes in the distribution and function of telocytes during different diseases; most studies of this kind have used animal models. Moreover, the causative relationship between a quantitative reduction of telocytes and disease development is disputable. It is important to consider that the modification of the cellular microenvironment of different organs during a disease can be the cause of telocyte loss, rather than the other way around.

5. Conclusions

Resolving the status of telocytes as an individual cell population will be important for morphologists, who still hesitate to include telocytes in histology and cellular biology textbooks and to incorporate them into the histological nomenclature. Tissue engineers are also interested in the final answer regarding the role of telocytes as stem cell “nurses” and their importance in regenerative medicine. Telocytes as “nurse” cells were reported, for instance, in the intestinal epithelium [16] and within the myocardium [137]; the discovery of new players in the regeneration and reparation of these organs would be revolutionary for future therapeutic applications. For pathologists and clinicians, the real role of telocytes in the pathogenesis of diseases with different etiologies (“telocytopathies” and “telocytomas”) remains unresolved. The most interesting aspect for immunologists is that a portion of the telocyte population may participate in the education of cells of the immune system [138]. In any case, future functional studies of telocytes in vivo will help to understand the mechanism by which telocytes contribute to tissue homeostasis in health and disease.

Funding

The study was partially supported by the VEGA grant agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic (No. 1/0086/17).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Balko, J.; Tonar, Z.; Varga, I. Memorix Histology; Triton: Prague, Czech Republic, 2018; 555p, ISBN 978-80-7553-577-1. [Google Scholar]
  2. Breathnach, C.S. Rudolf Virchow (1821–1902) and Die Cellularpathologie (1858). J. Ir. Coll. Phys. Surg. 2002, 31, 43–46. [Google Scholar]
  3. Byers, J.M., III. Rudolf Virchow—Father of cellular pathology. Am. J. Clin. Pathol. 1989, 92 (Suppl. 1), S2–S8. [Google Scholar] [PubMed]
  4. Popescu, L.M.; Hinescu, M.E.; Ionescu, N.; Ciontea, S.M.; Creţoiu, D.; Ardelean, C. Interstitial cells of Cajal in pancreas. J. Cell. Mol. Med. 2005, 9, 169–190. [Google Scholar] [CrossRef] [PubMed][Green Version]
  5. Manole, C.G.; Creţoiu, D. In Memoriam: Professor Laurentiu M. Popescu (1944–2015). Clin. Transl. Med. 2015, 4, 29. [Google Scholar] [CrossRef] [PubMed]
  6. Popescu, L.M.; Faussone-Pellegrini, M.S. TELOCYTES—A case of serendipity: The winding way from Interstitial Cells of Cajal (ICC), via Interstitial Cajal-Like Cells (ICLC) to telocytes. J. Cell. Mol. Med. 2010, 14, 729–740. [Google Scholar] [CrossRef]
  7. Vannucchi, M.G.; Traini, C. Interstitial cells of Cajal and telocytes in the gut: Twins, related or simply neighbor cells? Biomol. Concepts 2016, 7, 93–102. [Google Scholar] [CrossRef] [PubMed]
  8. FIPAT. Terminologia Histologica: International Terms for Human Cytology and Histology; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2008; 300p, ISBN 078177537X. [Google Scholar]
  9. Varga, I.; Blankova, A.; Konarik, M.; Baca, V.; Dvorakova, V.; Musil, V. The Terminologia Histologica after 10years: Inconsistencies, mistakes, and new proposals. Ann. Anat. 2018, 219, 65–75. [Google Scholar] [CrossRef] [PubMed]
  10. Díaz-Flores, L.; Gutiérrez, R.; García, M.P.; González, M.; Sáez, F.J.; Aparicio, F.; Diaz-Flores, L., Jr.; Madrid, J.F. Human resident CD34+ stromal cells/telocytes have progenitor capacity and are a source of αSMA+ cells during repair. Histol. Histopathol. 2015, 30, 615–627. [Google Scholar]
  11. Díaz-Flores, L.; Gutiérrez, R.; Díaz-Flores, L., Jr.; Goméz, M.G.; Sáez, F.J.; Madrid, J.F. Behaviour of telocytes during physiopathological activation. Semin. Cell Dev. Biol. 2016, 55, 50–61. [Google Scholar]
  12. Díaz-Flores, L.; Gutiérrez, R.; Pino García, M.; González, M.; Díaz-Flores, L.; Madrid, J.F. Telocytes as a source of progenitor cells in regeneration and repair through granulation tissue. Curr. Stem Cell Res. Ther. 2016, 11, 395–403. [Google Scholar] [CrossRef]
  13. Rusu, M.C.; Hostiuc, S.; Vrapciu, A.D.; Mogoantă, L.; Mănoiu, V.S.; Grigoriu, F. Subsets of telocytes: Myocardial telocytes. Ann. Anat. 2017, 209, 37–44. [Google Scholar] [CrossRef] [PubMed]
  14. Rusu, M.C.; Hostiuc, S. Critical review: Cardiac telocytes vs. cardiac lymphatic endothelial cells. Ann. Anat. 2019, 222, 40–54. [Google Scholar] [CrossRef] [PubMed]
  15. Varga, I.; Kyselovič, J.; Danišovič, Ľ.; Gálfiová, P.; Kachlík, D.; Polák, Š.; Klein, M. Recently discovered interstitial cells termed telocytes: Distinguishing cell-biological and histological facts from fictions. Biologia 2019. [Google Scholar] [CrossRef]
  16. Shoshkes-Carmel, M.; Wang, Y.J.; Wangensteen, K.J.; Tóth, B.; Kondo, A.; Massasa, E.E.; Itzkovitz, S.; Kaestner, K.H. Subepithelial telocytes are an important source of Wnts that supports intestinal crypts. Nature 2018, 557, 242–246. [Google Scholar] [CrossRef] [PubMed]
  17. Popescu, L.M.; Ciontea, S.M.; Cretoiu, D. Interstitial Cajal-like cells in human uterus and fallopian tube. Ann. N. Y. Acad. Sci. 2007, 1101, 139–165. [Google Scholar] [CrossRef] [PubMed]
  18. Creţoiu, S.M.; Popescu, L.M. Telocytes revisited. Biomol. Concepts 2014, 5, 353–369. [Google Scholar] [CrossRef] [PubMed]
  19. Creţoiu, S.M.; Creţoiu, D.; Popescu, L.M. Human myometrium—The ultrastructural 3D network of telocytes. J. Cell. Mol. Med. 2012, 16, 2844–2849. [Google Scholar] [CrossRef]
  20. Radu, B.M.; Banciu, A.; Banciu, D.D.; Radu, M.; Cretoiu, D.; Cretoiu, S.M. Calcium Signaling in Interstitial Cells: Focus on Telocytes. Int. J. Mol. Sci. 2017, 18, 397. [Google Scholar] [CrossRef]
  21. Rosenbaum, S.T.; Svalø, J.; Nielsen, K.; Larsen, T.; Jørgensen, J.C.; Bouchelouche, P. Immunolocalization and expression of small-conductance calcium-activated potassium channels in human myometrium. J. Cell. Mol. Med. 2012, 16, 3001–3008. [Google Scholar] [CrossRef][Green Version]
  22. Cretoiu, S.M.; Cretoiu, D.; Marin, A.; Radu, B.M.; Popescu, L.M. Telocytes: Ultrastructural, immunohistochemical and electrophysiological characteristics in human myometrium. Reproduction 2013, 145, 357–370. [Google Scholar] [CrossRef]
  23. Banciu, A.; Banciu, D.D.; Mustaciosu, C.C.; Radu, M.; Cretoiu, D.; Xiao, J.; Cretoiu, S.M.; Suciu, N.; Radu, B.M. Beta-Estradiol Regulates Voltage-Gated Calcium Channels and Estrogen Receptors in Telocytes from Human Myometrium. Int. J. Mol. Sci. 2018, 19, 1413. [Google Scholar] [CrossRef]
  24. Shim, W. Myocardial Telocytes: A New Player in Electric Circuitry of the Heart. Adv. Exp. Med. Biol. 2016, 913, 241–251. [Google Scholar] [PubMed]
  25. Mitrofanova, L.B.; Gorshkov, A.N.; Konovalov, P.V.; Krylova, J.S. Telocytes in the human sinoatrial node. J. Cell. Mol. Med. 2018, 22, 521–532. [Google Scholar] [CrossRef] [PubMed]
  26. Zheng, Y.; Bai, C.; Wang, X. Potential significance of telocytes in the pathogenesis of lung diseases. Expert Rev. Respir. Med. 2012, 6, 45–49. [Google Scholar] [CrossRef] [PubMed]
  27. Hussein, M.M.; Mokhtar, D.M. The roles of telocytes in lung development and angiogenesis: An immunohistochemical, ultrastructural, scanning electron microscopy and morphometrical study. Dev. Biol. 2018, 443, 137–152. [Google Scholar] [CrossRef]
  28. Kucybala, I.; Janas, P.; Ciuk, S.; Cholopiak, W.; Klimek-Piotrowska, W.; Holda, M.K. A comprehensive guide to telocytes and their great potential in cardiovascular system. Bratisl. Lek. Listy 2017, 118, 302–309. [Google Scholar] [CrossRef][Green Version]
  29. Nicolescu, M.I.; Popescu, L.M. Telocytes in the interstitium of human exocrine pancreas: Ultrastructural evidence. Pancreas 2012, 41, 949–956. [Google Scholar] [CrossRef]
  30. Padhi, S.; Sarangi, R.; Mallick, S. Pancreatic extragastrointestinal stromal tumors, interstitial Cajal like cells, and telocytes. JOP 2013, 14, 1–14. [Google Scholar]
  31. Xiao, J.; Wang, F.; Liu, Z.; Yang, C. Telocytes in liver: Electron microscopic and immunofluorescent evidence. J. Cell. Mol. Med. 2013, 17, 1537–1542. [Google Scholar] [CrossRef]
  32. Zhao, Y.; Chen, X.; Wang, F.; Yang, C. Hepatic Telocytes. Adv. Exp. Med. Biol. 2016, 913, 425–432. [Google Scholar]
  33. Shang, L.; Hosseini, M.; Liu, X.; Kisseleva, T.; Brenner, D.A. Human hepatic stellate cell isolation and characterization. J. Gastroenterol. 2018, 53, 6–17. [Google Scholar] [CrossRef] [PubMed]
  34. Parola, M.; Pinzani, M. Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. Mol. Asp. Med. 2018, 65, 37–55. [Google Scholar] [CrossRef] [PubMed]
  35. Pasternak, A.; Gil, K.; Matyja, A.; Gajda, M.; Sztefko, K.; Walocha, J.A.; Kulig, J.; Thor, P. Loss of gallbladder interstitial Cajal-like cells in patients with cholelithiasis. Neurogastroenterol. Motil. 2013, 25, e17–e24. [Google Scholar] [CrossRef]
  36. Pasternak, A.; Matyja, A.; Gil, K.; Gajda, M.; Tomaszewski, K.A.; Matyja, M.; Walocha, J.A.; Kulig, J. Interstitial cajal-like cells and bile lithogenicity in the pathogenesis of gall-stone disease. Pol. J. Surg. 2013, 85, 311–316. [Google Scholar] [CrossRef] [PubMed]
  37. Nicolescu, M.I.; Bucur, A.; Dinca, O.; Rusu, M.C.; Popescu, L.M. Telocytes in parotid glands. Anat. Rec. 2012, 295, 378–385. [Google Scholar] [CrossRef]
  38. Shafik, A.; Shafik, I.; el-Sibai, O. Identification of c-kit-positive cells in the human prostate: The interstitial cells of Cajal. Arch. Androl. 2005, 51, 345–351. [Google Scholar] [CrossRef]
  39. Gherghiceanu, M.; Popescu, L.M. Interstitial Cajal-like cells (ICLC) in human resting mammary gland stroma. Transmission electron microscope (TEM) identification. J. Cell. Mol. Med. 2005, 9, 893–910. [Google Scholar] [CrossRef][Green Version]
  40. Marini, M.; Rosa, I.; Ibba-Manneschi, L.; Manetti, M. Telocytes in skeletal, cardiac and smooth muscle interstitium: morphological and functional aspects. Histol Histopathol. 2018, 33, 1151–1165. [Google Scholar]
  41. Varga, I.; Danisovic, L.; Kyselovic, J.; Gazova, A.; Musil, P.; Miko, M.; Polak, S. The functional morphology and role of cardiac telocytes in myocardium regeneration. Can. J. Physiol. Pharmacol. 2016, 94, 1117–1121. [Google Scholar] [CrossRef][Green Version]
  42. Hostiuc, S.; Negoi, I.; Dogaroiu, C.; Drima, E.; Iancu, C.B. Cardiac telocytes. From basic science to cardiac diseases. I. Atrial fibrillation. Ann. Anat. 2018, 218, 83–87. [Google Scholar] [CrossRef]
  43. Hostiuc, S.; Marinescu, M.; Costescu, M.; Aluaș, M.; Negoi, I. Cardiac telocytes. From basic science to cardiac diseases. II. Acute myocardial infarction. Ann. Anat. 2018, 218, 18–27. [Google Scholar] [CrossRef] [PubMed]
  44. Bani, D.; Formigli, L.; Gherghiceanu, M.; Faussone-Pellegrini, M.S. Telocytes as supporting cells for myocardial tissue organization in developing and adult heart. J. Cell. Mol. Med. 2010, 14, 2531–2538. [Google Scholar] [CrossRef] [PubMed][Green Version]
  45. Zhou, J.; Wang, Y.; Zhu, P.; Sun, H.; Mou, Y.; Duan, C.; Yao, A.; Lv, S.; Wang, C. Distribution and characteristics of telocytes as nurse cells in the architectural organization of engineered heart tissues. Sci. China Life Sci. 2014, 57, 241–247. [Google Scholar] [CrossRef] [PubMed][Green Version]
  46. Richter, M.; Kostin, S. The failing human heart is characterized by decreased numbers of telocytes as result of apoptosis and altered extracellular matrix composition. J. Cell. Mol. Med. 2015, 19, 2597–2606. [Google Scholar] [CrossRef] [PubMed][Green Version]
  47. Varga, I.; Kyselovic, J.; Danihel, L.; Klein, M.; Barczi, T.; Galfiova, P.; Danisovic, L. Cardiac telocytes as principal interstitial cells for myocardial reparation and regeneration after infarction—Our hope. Bratisl. Lek. Listy 2017, 118, 721–723. [Google Scholar] [CrossRef] [PubMed]
  48. Cantarero, I.; Luesma, M.J.; Junquera, C. The primary cilium of telocytes in the vasculature: Electron microscope imaging. J. Cell. Mol. Med. 2011, 15, 2594–2600. [Google Scholar] [CrossRef]
  49. Li, H.; Zhang, H.; Yang, L.; Lu, S.; Ge, J. Telocytes in mice bone marrow: Electron microscope evidence. J. Cell. Mol. Med. 2014, 18, 975–978. [Google Scholar] [CrossRef]
  50. Luesma, M.J.; Gherghiceanu, M.; Popescu, L.M. Telocytes and stem cells in limbus and uvea of mouse eye. J. Cell. Mol. Med. 2013, 17, 1016–1024. [Google Scholar] [CrossRef]
  51. Petrea, C.E.; Rusu, M.C.; Mănoiu, V.S.; Vrapciu, A.D. Telocyte-like cells containing Weibel-Palade bodies in rat lamina fusca. Ann. Anat. 2018, 218, 88–94. [Google Scholar] [CrossRef]
  52. Dawidowicz, J.; Szotek, S.; Matysiak, N.; Mielańczyk, Ł.; Maksymowicz, K. Electron microscopy of human fascia lata: Focus on telocytes. J. Cell. Mol. Med. 2015, 19, 2500–2506. [Google Scholar] [CrossRef]
  53. Gherghiceanu, M.; Manole, C.G.; Popescu, L.M. Telocytes in endocardium: Electron microscope evidence. J. Cell. Mol. Med. 2010, 14, 2330–2334. [Google Scholar] [CrossRef] [PubMed]
  54. Kostin, S. Myocardial telocytes: A specific new cellular entity. J. Cell. Mol. Med. 2010, 14, 1917–1921. [Google Scholar] [CrossRef] [PubMed]
  55. Popescu, L.M.; Manole, C.G.; Gherghiceanu, M.; Ardelean, A.; Nicolescu, M.I.; Hinescu, M.E.; Kostin, S. Telocytes in human epicardium. J. Cell. Mol. Med. 2010, 14, 2085–2093. [Google Scholar] [CrossRef] [PubMed][Green Version]
  56. Yang, Y.; Sun, W.; Wu, S.M.; Xiao, J.; Kong, X. Telocytes in human heart valves. J. Cell. Mol. Med. 2014, 18, 759–765. [Google Scholar] [CrossRef] [PubMed][Green Version]
  57. Qi, G.; Lin, M.; Xu, M.; Manole, C.G.; Wang, X.; Zhu, T. Telocytes in the human kidney cortex. J. Cell. Mol. Med. 2012, 16, 3116–3122. [Google Scholar] [CrossRef] [PubMed][Green Version]
  58. Rusu, M.C.; Mogoantă, L.; Pop, F.; Dobra, M.A. Molecular phenotypes of the human kidney: Myoid stromal cells/telocytes and myoepithelial cells. Ann. Anat. 2018, 218, 95–104. [Google Scholar] [CrossRef] [PubMed]
  59. Matyja, A.; Gil, K.; Pasternak, A.; Sztefko, K.; Gajda, M.; Tomaszewski, K.A.; Matyja, M.; Walocha, J.A.; Kulig, J.; Thor, P. Telocytes: New insight into the pathogenesis of gallstone disease. J. Cell. Mol. Med. 2013, 17, 734–742. [Google Scholar] [CrossRef]
  60. Popescu, B.O.; Gherghiceanu, M.; Kostin, S.; Ceafalan, L.; Popescu, L.M. Telocytes in meninges and choroid plexus. Neurosci. Lett. 2012, 516, 265–269. [Google Scholar] [CrossRef]
  61. Díaz-Flores, L.; Gutiérrez, R.; Sáez, F.J.; Díaz-Flores, L., Jr.; Madrid, J.F. Telocytes in neuromuscular spindles. J. Cell. Mol. Med. 2013, 17, 457–465. [Google Scholar][Green Version]
  62. Rusu, M.C.; Nicolescu, M.I.; Jianu, A.M.; Lighezan, R.; Mănoiu, V.S.; Păduraru, D. Esophageal telocytes and hybrid morphologies. Cell Biol. Int. 2012, 36, 1079–1088. [Google Scholar] [CrossRef]
  63. Vannucchi, M.G.; Traini, C.; Manetti, M.; Ibba-Manneschi, L.; Faussone-Pellegrini, M.S. Telocytes express PDGFRα in the human gastrointestinal tract. J. Cell. Mol. Med. 2013, 17, 1099–1108. [Google Scholar] [CrossRef] [PubMed][Green Version]
  64. Bosco, C.; Díaz, E.; Gutiérrez, R.; González, J.; Parra-Cordero, M.; Rodrigo, R.; Barja, P. A putative role for telocytes in placental barrier impairment during preeclampsia. Med. Hypotheses 2015, 84, 72–77. [Google Scholar] [CrossRef] [PubMed]
  65. Nizyaeva, N.V.; Sukhacheva, T.V.; Serov, R.A.; Kulikova, G.V.; Nagovitsyna, M.N.; Kan, N.E.; Tyutyunnik, V.L.; Pavlovich, S.V.; Poltavtseva, R.A.; Yarotskaya, E.L.; et al. Ultrastructural and immunohistochemical features of telocytes in placental villi in preeclampsia. Sci. Rep. 2018, 8, 3453. [Google Scholar] [CrossRef] [PubMed]
  66. Corradi, L.S.; Jesus, M.M.; Fochi, R.A.; Vilamaior, P.S.; Justulin, L.A., Jr.; Góes, R.M.; Felisbino, S.L.; Taboga, S.R. Structural and ultrastructural evidence for telocytes in prostate stroma. J. Cell. Mol. Med. 2013, 17, 398–406. [Google Scholar] [CrossRef] [PubMed][Green Version]
  67. Marini, M.; Manetti, M.; Rosa, I.; Ibba-Manneschi, L.; Sgambati, E. Telocytes in human fetal skeletal muscle interstitium during early myogenesis. Acta Histochem. 2018, 120, 397–404. [Google Scholar] [CrossRef] [PubMed]
  68. Rusu, M.C.; Mirancea, N.; Mănoiu, V.S.; Vâlcu, M.; Nicolescu, M.I.; Păduraru, D. Skin telocytes. Ann. Anat. 2012, 194, 359–367. [Google Scholar] [CrossRef] [PubMed]
  69. Cretoiu, D.; Cretoiu, S.M.; Simionescu, A.A.; Popescu, L.M. Telocytes, a distinct type of cell among the stromal cells present in the lamina propria of jejunum. Histol. Histopathol. 2012, 27, 1067–1078. [Google Scholar] [PubMed]
  70. Chang, Y.; Li, C.; Gan, L.; Li, H.; Guo, Z. Telocytes in the spleen. PLoS ONE 2015, 10, e0138851. [Google Scholar] [CrossRef]
  71. Rosa, I.; Marini, M.; Guasti, D.; Ibba-Manneschi, L.; Manetti, M. Morphological evidence of telocytes in human synovium. Sci. Rep. 2018, 8, 3581. [Google Scholar] [CrossRef]
  72. Rusu, M.C.; Loreto, C.; Mănoiu, V.S. Network of telocytes in the temporomandibular joint disc of rats. Acta Histochem. 2014, 116, 663–668. [Google Scholar] [CrossRef]
  73. Rusu, M.C.; Jianu, A.M.; Mirancea, N.; Didilescu, A.C.; Mănoiu, V.S.; Păduraru, D. Tracheal telocytes. J. Cell. Mol. Med. 2012, 16, 401–405. [Google Scholar] [CrossRef] [PubMed][Green Version]
  74. Popescu, L.M.; Gherghiceanu, M.; Suciu, L.C.; Manole, C.G.; Hinescu, M.E. Telocytes and putative stem cells in the lungs: Electron microscopy, electron tomography and laser scanning microscopy. Cell Tissue Res. 2011, 345, 391–403. [Google Scholar] [CrossRef]
  75. Hinescu, M.E.; Gherghiceanu, M.; Suciu, L.; Popescu, L.M. Telocytes in pleura: Two- and three-dimensional imaging by transmission electron microscopy. Cell Tissue Res. 2011, 343, 389–397. [Google Scholar] [CrossRef] [PubMed]
  76. Rusu, M.C.; Mănoiu, V.S.; Creţoiu, D.; Creţoiu, S.M.; Vrapciu, A.D. Stromal cells/telocytes and endothelial progenitors in the perivascular niches of the trigeminal ganglion. Ann. Anat. 2018, 218, 141–155. [Google Scholar] [CrossRef] [PubMed]
  77. Vannucchi, M.G.; Traini, C.; Guasti, D.; Del Popolo, G.; Faussone-Pellegrini, M.S. Telocytes subtypes in human urinary bladder. J. Cell. Mol. Med. 2014, 18, 2000–2008. [Google Scholar] [CrossRef] [PubMed][Green Version]
  78. Rusu, M.C.; Pop, F.; Petre, N.; Dobra, M.A. The sheath of Waldeyer is not a specific anatomical trait of the ureterovesical junction. Morphologie 2018, 102, 6–11. [Google Scholar] [CrossRef]
  79. Cretoiu, S.M. Immunohistochemistry of telocytes in the uterus and fallopian tubes. Adv. Exp. Med. Biol. 2016, 913, 335–357. [Google Scholar]
  80. Hatta, K.; Huang, M.L.; Weisel, R.D.; Li, R.K. Culture of rat endometrial telocytes. J. Cell. Mol. Med. 2012, 16, 1392–1396. [Google Scholar] [CrossRef][Green Version]
  81. Klein, M.; Urban, L.; Deckov, I.; Danisovic, L.; Polak, S.; Danihel, L.; Varga, I. Distribution of telocytes in the corpus and cervix of human uterus: An immunohistochemical study. Biologia 2017, 72, 1217–1223. [Google Scholar] [CrossRef]
  82. Shafik, A.; El-Sibai, O.; Shafik, I.; Shafik, A.A. Immunohistochemical identification of the pacemaker cajal cells in the normal human vagina. Arch. Gynecol. Obstet. 2005, 272, 13–16. [Google Scholar] [CrossRef]
  83. Suciu, L.; Nicolescu, M.I.; Popescu, L.M. Cardiac telocytes: Serial dynamic images in cell culture. J. Cell. Mol. Med. 2010, 14, 2687–2692. [Google Scholar] [CrossRef]
  84. Faussone-Pellegrini, M.S.; Bani, D. Relationships between telocytes and cardiomyocytes during pre- and post-natal life. J. Cell. Mol. Med. 2010, 14, 1061–1063. [Google Scholar] [CrossRef] [PubMed]
  85. Popescu, L.M.; Manole, E.; Serboiu, C.S.; Manole, C.G.; Suciu, L.C.; Gherghiceanu, M.; Popescu, B.O. Identification of telocytes in skeletal muscle interstitium: Implication for muscle regeneration. J. Cell. Mol. Med. 2011, 15, 1379–1392. [Google Scholar] [CrossRef] [PubMed]
  86. Sanches, B.; Maldarine, J.S.; Zani, B.C.; Tamarindo, G.H.; Biancardi, M.F.; Santos, F.; Rahal, P.; Góes, R.M.; Felisbino, S.L.; Vilamaior, P.; et al. Telocytes play a key role in prostate tissue organisation during the gland morphogenesis. J. Cell. Mol. Med. 2017, 21, 3309–3321. [Google Scholar] [CrossRef] [PubMed][Green Version]
  87. Zheng, Y.; Bai, C.; Wang, X. Telocyte morphologies and potential roles in diseases. J. Cell. Physiol. 2012, 227, 2311–2317. [Google Scholar] [CrossRef] [PubMed]
  88. Song, D.; Cretoiu, D.; Wang, X. Mitochondrial DNA in Telocytes. Adv. Exp. Med. Biol. 2017, 1038, 55–70. [Google Scholar]
  89. Cretoiu, D.; Radu, B.M.; Banciu, A.; Banciu, D.D.; Cretoiu, S.M. Telocytes heterogeneity: From cellular morphology to functional evidence. Semin. Cell Dev. Biol. 2017, 64, 26–39. [Google Scholar] [CrossRef]
  90. Janas, P.; Kucybała, I.; Radoń-Pokracka, M.; Huras, H. Telocytes in the female reproductive system: An overview of up-to-date knowledge. Adv. Clin. Exp. Med. 2018, 27, 559–565. [Google Scholar] [CrossRef]
  91. Zhang, B.; Yang, C.; Qiao, L.; Li, Q.; Wang, C.; Yan, X.; Lin, J. Telocytes: A potential defender in the spleen of Npc1 mutant mice. J. Cell. Mol. Med. 2017, 21, 848–859. [Google Scholar] [CrossRef]
  92. Rusu, M.C.; Cretoiu, D.; Vrapciu, A.D.; Hostiuc, S.; Dermengiu, D.; Manoiu, V.S.; Cretoiu, S.M.; Mirancea, N. Telocytes of the human adult trigeminal ganglion. Cell Biol. Toxicol. 2016, 32, 199–207. [Google Scholar] [CrossRef]
  93. Enciu, A.M.; Popescu, L.M. Telopodes of telocytes are influenced in vitro by redox conditions and ageing. Mol. Cell. Biochem. 2015, 410, 165–174. [Google Scholar] [CrossRef] [PubMed]
  94. Yang, P.; Zhu, X.; Wang, L.; Ahmed, N.; Huang, Y.; Chen, H.; Zhang, Q.; Ullah, S.; Liu, T.; Guo, D.; et al. Cellular Evidence of Telocytes as Novel Interstitial Cells Within the Magnum of Chicken Oviduct. Cell Transplant. 2017, 26, 135–143. [Google Scholar] [CrossRef] [PubMed]
  95. Faussone Pellegrini, M.S.; Popescu, L.M. Telocytes. Biomol Concepts 2011, 2, 481–489. [Google Scholar] [CrossRef] [PubMed]
  96. Popescu, L.M.; Curici, A.; Wang, E.; Zhang, H.; Hu, S.; Gherghiceanu, M. Telocytes and putative stem cells in ageing human heart. J. Cell. Mol. Med. 2014, 19, 31–45. [Google Scholar] [CrossRef]
  97. Yang, X.J. Telocytes in Inflammatory Gynaecologic Diseases and Infertility. Adv. Exp. Med. Biol. 2016, 913, 263–285. [Google Scholar] [PubMed]
  98. Li, Y.Y.; Zhang, S.; Li, Y.G.; Wang, Y. Isolation, culture, purification and ultrastructural investigation of cardiac telocytes. Mol. Med. Rep. 2016, 14, 1194–1200. [Google Scholar] [CrossRef] [PubMed][Green Version]
  99. Awad, M.; Ghanem, M.E. Localization of telocytes in rabbits testis: Histological and immunohistochemical approach. Microsc. Res. Tech. 2018, 81, 1268–1274. [Google Scholar] [CrossRef] [PubMed]
  100. Zhou, Q.; Wei, L.; Zhong, C.; Fu, S.; Bei, Y.; Huică, R.I.; Wang, F.; Xiao, J. Cardiac telocytes are double positive for CD34/PDGFR-α. J. Cell. Mol. Med. 2015, 19, 2036–2042. [Google Scholar] [CrossRef] [PubMed][Green Version]
  101. Suciu, L.C.; Popescu, B.O.; Kostin, S.; Popescu, L.M. Platelet-derived growth factor receptor-β-positive telocytes in skeletal muscle interstitium. J. Cell. Mol. Med. 2012, 16, 701–707. [Google Scholar] [CrossRef] [PubMed][Green Version]
  102. Abd-Elhafeez, H.H.; Soliman, S.A. New Description of Telocyte Sheaths in the Bovine Uterine Tube: An Immunohistochemical and Scanning Microscopic Study. Cells Tissues Organs 2017, 203, 295–315. [Google Scholar] [CrossRef] [PubMed]
  103. Abd-Elkareem, M. Cell-specific immuno-localization of progesterone receptor alpha in the rabbit ovary during pregnancy and after parturition. Anim. Reprod. Sci. 2017, 180, 100–120. [Google Scholar] [CrossRef] [PubMed]
  104. Chaitow, L. Telocytes: Connective tissue repair and communication cells. J. Bodyw. Mov. Ther. 2017, 21, 231–233. [Google Scholar] [CrossRef] [PubMed]
  105. Creţoiu, D.; Xu, J.; Xiao, J.; Creţoiu, S.M. Telocytes and their extracellular vesicles—Evidence and hypotheses. Int. J. Mol. Sci. 2016, 17, 1322. [Google Scholar] [CrossRef] [PubMed]
  106. Edelstein, L.; Fuxe, K.; Levin, M.; Popescu, B.O.; Smythies, J. Telocytes in their context with other intercellular communication agents. Semin. Cell Dev. Biol. 2016, 55, 9–13. [Google Scholar] [CrossRef] [PubMed]
  107. Smythies, J.; Edelstein, L. Telocytes, exosomes, gap junctions and the cytoskeleton: The makings of a primitive nervous system? Front. Cell. Neurosci. 2014, 7, 278. [Google Scholar] [CrossRef] [PubMed]
  108. Mostafa, R.M.; Moustafa, Y.M.; Hamdy, H. Interstitial cells of Cajal, the Maestro in health and disease. World J. Gastroenterol. 2010, 16, 3239–3248. [Google Scholar] [CrossRef] [PubMed]
  109. Gopie, P.; Mei, L.; Faber, A.C.; Grossman, S.R.; Smith, S.C.; Boikos, S.A. Classification of gastrointestinal stromal tumor syndromes. Endocr. Relat. Cancer 2018, 25, R49–R58. [Google Scholar] [CrossRef] [PubMed][Green Version]
  110. Niinuma, T.; Suzuki, H.; Sugai, T. Molecular characterization and pathogenesis of gastrointestinal stromal tumor. Transl. Gastroenterol. Hepatol. 2018, 3, 2. [Google Scholar] [CrossRef]
  111. Ricci, R.; Giustiniani, M.C.; Gessi, M.; Lanza, P.; Castri, F.; Biondi, A.; Persiani, R.; Vecchio, F.M.; Risio, M. Telocytes are the physiological counterpart of inflammatory fibroid polyps and PDGFRA-mutant GISTs. J. Cell. Mol. Med. 2018, 22, 4856–4862. [Google Scholar] [CrossRef]
  112. Padhi, S.; Nayak, H.K. Primary extragastrointestinal stromal tumours in the hepatobiliary tree and telocytes. Adv. Exp. Med. Biol. 2016, 913, 207–228. [Google Scholar]
  113. You, Y.H.; Zhang, Y. Primary prostatic extragastrointestinal stromal tumor: A case report and literature review. J. Int. Med. Res. 2018. [Ahead of print]. [Google Scholar] [CrossRef] [PubMed]
  114. Liu, Q.Y.; Kan, Y.Z.; Zhang, M.Y.; Sun, T.Y.; Kong, L.F. Primary extragastrointestinal stromal tumor arising in the vaginal wall: Significant clinicopathological characteristics of a rare aggressive soft tissue neoplasm. World J. Clin. Cases 2016, 4, 118–123. [Google Scholar] [CrossRef] [PubMed]
  115. Peitsidis, P.; Zarganis, P.; Trichia, H.; Vorgias, G.; Smith, J.R.; Akrivos, T. Extragastrointestinal stromal tumor mimicking a uterine tumor. A rare clinical entity. Int. J. Gynecol. Cancer 2008, 18, 1115–1118. [Google Scholar] [CrossRef] [PubMed]
  116. Ko, K.; Shimanuki, K.; Sakamoto, W.; Hara, K.; Uchida, E. Extragastrointestinal stromal tumor of the inferior vena cava: A case report. Surg. Case Rep. 2017, 3, 53. [Google Scholar] [CrossRef] [PubMed]
  117. Fu, S.; Wang, F.; Cao, Y.; Huang, Q.; Xiao, J.; Yang, C.; Popescu, L.M. Telocytes in human liver fibrosis. J. Cell. Mol. Med. 2015, 19, 676–683. [Google Scholar] [CrossRef] [PubMed][Green Version]
  118. Manetti, M.; Rosa, I.; Messerini, L.; Ibba-Manneschi, L. Telocytes are reduced during fibrotic remodelling of the colonic wall in ulcerative colitis. J. Cell. Mol. Med. 2015, 19, 62–73. [Google Scholar] [CrossRef]
  119. Wang, X.Y.; Zarate, N.; Soderholm, J.D.; Bourgeois, J.M.; Liu, L.W.; Huizinga, J.D. Ultrastructural injury to interstitial cells of Cajal and communication with mast cells in Crohn’s disease. Neurogastroenterol. Motil. 2007, 19, 349–364. [Google Scholar] [CrossRef]
  120. Alunno, A.; Ibba-Manneschi, L.; Bistoni, O.; Rosa, I.; Caterbi, S.; Gerli, R.; Manetti, M. Telocytes in minor salivary glands of primary Sjögren’s syndrome: Association with the extent of inflammation and ectopic lymphoid neogenesis. J. Cell. Mol. Med. 2015, 19, 1689–1696. [Google Scholar] [CrossRef]
  121. Sun, X.; Zheng, M.; Zhang, M.; Qian, M.; Zheng, Y.; Li, M.; Cretoiu, D.; Chen, C.; Chen, L.; Popescu, L.M.; et al. Differences in the expression of chromosome 1 genes between lung telocytes and other cells: Mesenchymal stem cells, fibroblasts, alveolar type II cells, airway epithelial cells and lymphocytes. J. Cell. Mol. Med. 2014, 18, 801–810. [Google Scholar] [CrossRef]
  122. Mehrazma, M.; Tanzifi, P.; Rakhshani, N. Changes in structure, interstitial cajal-like cells and apoptosis of smooth muscle cells in congenital ureteropelvic junction obstruction. Iran. J. Pediatr. 2014, 24, 105–110. [Google Scholar] [CrossRef]
  123. Gevaert, T.; De Vos, R.; Everaerts, W.; Libbrecht, L.; Van Der Aa, F.; van den Oord, J.; Roskams, T.; De Ridder, D. Characterization of upper lamina propria interstitial cells in bladders from patients with neurogenic detrusor overactivity and bladder pain syndrome. J. Cell. Mol. Med. 2011, 15, 2586–2593. [Google Scholar] [CrossRef] [PubMed][Green Version]
  124. Gevaert, T.; Lerut, E.; Joniau, S.; Franken, J.; Roskams, T.; De Ridder, D. Characterization of subepithelial interstitial cells in normal and pathological human prostate. Histopathology 2014, 65, 418–428. [Google Scholar] [CrossRef] [PubMed]
  125. Yang, X.J.; Yang, J.; Liu, Z.; Yang, G.; Shen, Z.J. Telocytes damage in endometriosis-affected rat oviduct and potential impact on fertility. J. Cell. Mol. Med. 2015, 19, 452–462. [Google Scholar] [CrossRef] [PubMed]
  126. Liu, T.; Wang, S.; Li, Q.; Huang, Y.; Chen, C.; Zheng, J. Telocytes as potential targets in a cyclophosphamide-induced animal model of premature ovarian failure. Mol. Med. Rep. 2016, 14, 2415–2422. [Google Scholar] [CrossRef] [PubMed][Green Version]
  127. Varga, I.; Klein, M.; Urban, L.; Danihel, L., Jr.; Polak, S.; Danihel, L., Sr. Recently discovered interstitial cells “telocytes” as players in the pathogenesis of uterine leiomyomas. Med. Hypotheses 2018, 110, 64–67. [Google Scholar] [CrossRef] [PubMed]
  128. Manole, C.G.; Gherghiceanu, M.; Simionescu, O. Telocyte dynamics in psoriasis. J. Cell. Mol. Med. 2015, 19, 1504–1519. [Google Scholar] [CrossRef] [PubMed][Green Version]
  129. Mirancea, N.; Moroşanu, A.M.; Mirancea, G.V.; Juravle, F.D.; Mănoiu, V.S. Infrastructure of the telocytes from tumor stroma in the skin basal and squamous cell carcinomas. Rom. J. Morphol. Embryol. 2013, 54, 1025–1037. [Google Scholar] [PubMed]
  130. Mou, Y.; Wang, Y.; Li, J.; Lü, S.; Duan, C.; Du, Z.; Yang, G.; Chen, W.; Zhao, S.; Zhou, J.; et al. Immunohistochemical characterization and functional identification of mammary gland telocytes in the self-assembly of reconstituted breast cancer tissue in vitro. J. Cell. Mol. Med. 2013, 17, 65–75. [Google Scholar] [CrossRef] [PubMed]
  131. Manetti, M.; Rosa, I.; Messerini, L.; Guiducci, S.; Matucci-Cerinic, M.; Ibba-Manneschi, L. A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis. J. Cell. Mol. Med. 2014, 18, 253–262. [Google Scholar] [CrossRef][Green Version]
  132. Marini, M.; Mencucci, R.; Rosa, I.; Favuzza, E.; Guasti, D.; Ibba-Manneschi, L.; Manetti, M. Telocytes in normal and keratoconic human cornea: An immunohistochemical and transmission electron microscopy study. J. Cell. Mol. Med. 2017, 21, 3602–3611. [Google Scholar] [CrossRef]
  133. Galrinho, R.D.; Manole, C.G.; Vinereanu, D. Telocytes—A hope for cardiac repair after myocardial infarction. Maedica 2016, 11, 325–329. [Google Scholar] [PubMed]
  134. Hinescu, M.E.; Gherghiceanu, M.; Mandache, E.; Ciontea, S.M.; Popescu, L.M. Interstitial Cajal-like cells (ICLC) in atrial myocardium: Ultrastructural and immunohistochemical characterization. J. Cell. Mol. Med. 2006, 10, 243–257. [Google Scholar] [CrossRef] [PubMed]
  135. Li, Y.; Zhang, X.; Gao, J.; Xiao, H.; Xu, M. Increased telocytes involved in the proliferation of vascular smooth muscle cells in rat carotid artery balloon injury. Sci. China Life Sci. 2016, 59, 678–685. [Google Scholar] [CrossRef][Green Version]
  136. Szotek, S.; Dawidowicz, J.; Eyden, B.; Matysiak, N.; Czogalla, A.; Dudzik, G.; Leśniewicz, A.; Maksymowicz, K. Morphological features of fascia lata in relation to fascia diseases. Ultrastruct. Pathol. 2016, 40, 297–310. [Google Scholar] [CrossRef] [PubMed]
  137. Popescu, L.M.; Fertig, E.T.; Gherghiceanu, M. Reaching out: Junctions between cardiac telocytes and cardiac stem cells in culture. J. Cell. Mol. Med. 2016, 20, 370–380. [Google Scholar] [CrossRef] [PubMed]
  138. Jiang, X.J.; Creţoiu, D.; Shen, Z.J.; Yang, X.J. An in vitro investigation of telocytes-educated macrophages: Morphology, heterocellular junctions, apoptosis and invasion analysis. J. Transl. Med. 2018, 16, 85. [Google Scholar] [CrossRef] [PubMed]
Table 1. Typical locations of telocytes in mammals (organs are in alphabetical order).
Table 1. Typical locations of telocytes in mammals (organs are in alphabetical order).
Organ or TissueReferences
Blood vesselsCantarero et al. [48]
Bone marrowLi et al. [49]
Eye (sclera, limbus, uvea and lamina fusca)Luesma et al. [50]; Petrea et al. [51]
Fascia lataDawidowicz et al. [52]
Heart, including endocardium, myocardium, epicardium and heart valvesGherghiceanu et al. [53]; Kostin [54]; Popescu et al. [55]; Yang et al. [56]
KidneyQi et al. [57]; Rusu et al. [58]
Liver and gallbladderXiao et al. [31]; Matyja et al. [59]
Mammary glandGherghiceanu and Popescu [39]
Meninges and choroid plexusPopescu et al. [60]
Neuromuscular spindlesDíaz-Flores et al. [61]
Esophagus and stomachRusu et al. [62]; Vannucchi et al. [63]
Pancreas, exocrine partNicolescu and Popescu [29]
Placenta, placental chorionic villi Bosco et al. [64]; Nizyaeva et al. [65]
ProstateShafik et al. [38]; Corradi et al. [66]
Salivary glandsNicolescu et al. [37]
Skeletal muscle (within its interstitium) Marini et al. [67]
SkinRusu et al. [68]
Small and large intestinesCretoiu et al. [69]; Vannucchi et al. [63]
SpleenChang et al. [70]
Synovial membraneRosa et al. [71]
Temporomandibular joint discRusu et al. [72]
Trachea, lungs and pleuraRusu et al. [73]; Popescu et al. [74]; Hinescu et al. [75]
Trigeminal nerve gangliaRusu et al. [76]
Urinary bladder and uretersVannucchi et al. [77]; Rusu et al. [78]
Uterine tubes and uterus, including endometrium, myometrium and cervixPopescu et al. [17]; Cretoiu 2016 [79]; Hatta et al. 2012 [80]; Creţoiu et al. [19]; Klein et al. [81]
VaginaShafik et al. [82]
Table 2. Summary of diseases associated with a reduced number or functional disorder of telocytes.
Table 2. Summary of diseases associated with a reduced number or functional disorder of telocytes.
Organ SystemOrgan, TissueDisease, “Telocytopathy”Authors and Year of PublicationJournal Name and Impact Factor
Digestive systemGallbladderGallstonesMatyja et al. [59] J Cell Mol Med
3.698
LiverLiver fibrosisFu et al. [117]J Cell Mol Med
4.938
PancreasExtragastrointestinal stromal tumorPadhi et al. [30]JOP
0.0
GutUlcerative colitisManetti et al. [118]J Cell Mol Med
4.938
GutCrohn’s diseaseWang et al. [119]Neurogastroenterol Motil
3.364
Salivary glandsSjögren’s diseaseAlunno et al. [120]J Cell Mol Med
4.938
Gastric antrumInflammatory fibroid polypRicci et al. [111]J Cell Mol Med
4.302
Respiratory systemLungsFibrosis after pneumoniaSun et al. [121]J Cell Mol Med
4.014
LarynxReinke’s edema Díaz-Flores et al. [11]Semin Cell Dev Biol
6.614
Urinary systemKidneyUreteropelvic junction obstructionMehrazma et al. [122]Iran J Pediatr
0.522
Urinary bladderNeurogenic detrusor overactivityGevaert et al. [123]J Cell Mol Med
4.125
Male genital systemTestesHyperplasia of Leydig cells in undescended testes (cryptorchidism)Díaz-Flores et al. [11]Semin Cell Dev Biol
6.614
ProstateProstate cancer, benign prostate hyperplasiaGevaert et al. [124]Histopathology
3.453
Female genital systemPlacentaPreeclampsiaBosco et al. [64]Med Hypotheses
1.136
Uterine tubeEndometriosis, uterine tube damage, infertilityYang et al. [125]J Cell Mol Med
4.938
OvariesPremature ovarian failureLiu et al. [126]Mol Med Rep
1.692
UterusUterine fibroids (leiomyomas)Varga et al. [127]Med Hypotheses
1.120
Skin and skin derivativesSkinPsoriasisManole et al. [128]J Cell Mol Med
4.938
SkinBasal cell carcinoma, squamous cell carcinomaMirancea et al. [129]Rom J Morphol Embryol
0.723
Mammary glandBreast cancerMou et al. [130]J Cell Mol Med
3.698
Skin and internal organsSystemic sclerosisManetti et al. [131]J Cell Mol Med
4.014
Sensory systemEyeKeratoconusMarini et al. [132]J Cell Mol Med
4.302
Cardiovascular systemHeartHeart failureRichter and Kostin [46]J Cell Mol Med
4.938
HeartHeart attackGalrinho et al. [133]Maedica (Buchar)
0.0
HeartArrhythmiaHinescu et al. [134]J Cell Mol Med
6.555
Blood vesselsVascular hyperplastic diseasesLi et al. [135]Sci China Life Sci
2.781
Connective tissueFascia lataVarious degenerative changesSzotek et al. [136]Ultrastruct Pathol
0.694

© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Medicina EISSN 1010-660X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top